De novo autoimmune hepatitis after interferon treatment in a liver transplant recipient with common variable immunodeficiency.
Immunology, Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocío/CSIC/University of Seville, Spain. Electronic address: iaguilera-ibis@us.es.
Isabel
I
Aguilera
Digestive Diseases, Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocío/CSIC/University of Seville, Spain.
Jose Manuel
JM
Sousa
Liver Transplant Unit, Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocío/CSIC/University of Seville, Spain.
Miguel Angel
MA
Gómez-Bravo
Immunology, Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocío/CSIC/University of Seville, Spain.
Antonio
A
Núñez-Roldán
D000998:Antiviral Agents / Q000009:adverse effects*; D017074:Common Variable Immunodeficiency / Q000150:complications*; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D019693:Hepatitis, Autoimmune / Q000209:etiology*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008103:Liver Cirrhosis / Q000601:surgery / Q000821:virology; D016031:Liver Transplantation; D012254:Ribavirin / Q000627:therapeutic use; D055815:Young Adult
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin